Guidance for Industry - Priority Review of Drug Submissions (French, HTML)

View metadata and access the original French HTML file: Guidance for Industry - Priority Review of Drug Submissions.

Format

HTML

Access

file-only

Publisher-reported update

2021-07-07

This guidance aims to articulate Health Canada's expectations and generate a level of consistency regarding the interpretation of the Priority Review of Drug Submissions policy and the filing of a Priority Review request. Additional clarification of the process by which the Priority Review request is assessed is provided.

Access original file